2-233689021-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019075.4(UGT1A10):​c.855+51644C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.393 in 152,004 control chromosomes in the GnomAD database, including 11,933 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 11933 hom., cov: 32)

Consequence

UGT1A10
NM_019075.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.295

Publications

10 publications found
Variant links:
Genes affected
UGT1A10 (HGNC:12531): (UDP glucuronosyltransferase family 1 member A10) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity on mycophenolic acid, coumarins, and quinolines. [provided by RefSeq, Jul 2008]
UGT1A8 (HGNC:12540): (UDP glucuronosyltransferase family 1 member A8) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity with many substrates including coumarins, phenols, anthraquinones, flavones, and some opioids. [provided by RefSeq, Jul 2008]
UGT1A7 (HGNC:12539): (UDP glucuronosyltransferase family 1 member A7) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has moderate glucuronidase activity with phenols. [provided by RefSeq, Jul 2008]
UGT1A9 (HGNC:12541): (UDP glucuronosyltransferase family 1 member A9) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenols. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_019075.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UGT1A10
NM_019075.4
MANE Select
c.855+51644C>G
intron
N/ANP_061948.1Q5DT02
UGT1A8
NM_019076.5
MANE Select
c.855+70459C>G
intron
N/ANP_061949.3
UGT1A7
NM_019077.3
MANE Select
c.855+6229C>G
intron
N/ANP_061950.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UGT1A10
ENST00000344644.10
TSL:1 MANE Select
c.855+51644C>G
intron
N/AENSP00000343838.5Q9HAW8-1
UGT1A9
ENST00000354728.5
TSL:1 MANE Select
c.855+16232C>G
intron
N/AENSP00000346768.4O60656-1
UGT1A7
ENST00000373426.4
TSL:1 MANE Select
c.855+6229C>G
intron
N/AENSP00000362525.3Q9HAW7-1

Frequencies

GnomAD3 genomes
AF:
0.393
AC:
59736
AN:
151886
Hom.:
11936
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.375
Gnomad AMI
AF:
0.503
Gnomad AMR
AF:
0.338
Gnomad ASJ
AF:
0.465
Gnomad EAS
AF:
0.230
Gnomad SAS
AF:
0.456
Gnomad FIN
AF:
0.517
Gnomad MID
AF:
0.398
Gnomad NFE
AF:
0.401
Gnomad OTH
AF:
0.371
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.393
AC:
59752
AN:
152004
Hom.:
11933
Cov.:
32
AF XY:
0.398
AC XY:
29565
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.375
AC:
15540
AN:
41426
American (AMR)
AF:
0.338
AC:
5167
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.465
AC:
1613
AN:
3468
East Asian (EAS)
AF:
0.231
AC:
1194
AN:
5174
South Asian (SAS)
AF:
0.455
AC:
2194
AN:
4820
European-Finnish (FIN)
AF:
0.517
AC:
5459
AN:
10560
Middle Eastern (MID)
AF:
0.387
AC:
113
AN:
292
European-Non Finnish (NFE)
AF:
0.401
AC:
27236
AN:
67948
Other (OTH)
AF:
0.368
AC:
778
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1840
3679
5519
7358
9198
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
584
1168
1752
2336
2920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.278
Hom.:
811
Bravo
AF:
0.376
Asia WGS
AF:
0.335
AC:
1169
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
2.3
DANN
Benign
0.60
PhyloP100
-0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10171367; hg19: chr2-234597667; API